Morning Market Losers By: Benzinga via Benzinga March 26, 2014 at 09:53 AM EDT Exelixis (NASDAQ: EXEL) fell 36.03% to $4.12 after the company issued an update on ongoing COMET-1 phase 3 pivotal trial in men with ... Read More >> Related Stocks: Ballard Power Sys Exelixis Inc Francesca's Holdings Insmed Inc Reeds Inc